IN THIS SECTION
FEATURED NEWS
FEATURED EVENTS
FDA Communications
News/Updates from the U.S. Food and Drug Administration
-
Medtronic Recalls TurboHawk Plus Directional Atherectomy System Due to Risk of Tip Damage During Use
-
FDA Advisory Panel Recommendations on Lifelong Surveillance and Long-Term Postmarket Data Collection for Patients with AAA Endovascular Aortic Repair – Letter to Health Care Providers
-
The FDA has issued a Class 1 Device Recall for HawkOne – Please see the FDA’s Notice for Further Notification
-
FDA has issued an important Safety Communication Update on the Endologix AFX
-
Notice AAA Advisory Committee Meeting November 2-3, 2021
-
Update from Medtronic on the voluntary recall of their Valiant Navion Thoracic Stent Graft
-
FDA designates recalls of two vascular catheters as Class I
-
Penumbra’s Urgent Voluntary Recall of JET 7 Catheters with Xtra Flex Technology Due to Increased Risk of Mortality and Serious Injury – Urgent Letter to Health Care Providers
-
FDA Update: Importance of At Least Yearly, Lifelong Follow-Up with Use of Endologix AFX Endovascular Graft Systems
